Skip to content

Online survey on clinical care, health problems and psychosocial stress during the corona pandemic in children and adolescents with chronic inflammatory bowel disease (IBD) (COVID19-CED-PÄD)

Online survey on clinical care, health problems and psychosocial stress during the corona pandemic in children and adolescents with chronic inflammatory bowel disease (IBD) (COVID19-CED-PÄD) - COVID19-CED-PÄD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022500
Enrollment
300
Registered
2020-08-21
Start date
2020-08-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K50 K51 K52 U07.1

Interventions

Group 1: We kindly ask parents together with their child or their adolescent with IBD to fill out the online questionnaire. The survey takes about 30 minutes.

Sponsors

Klinikum der Universität München (LMU Klinikum)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 20 Years

Inclusion criteria

Inclusion criteria: Patients (male, female, divers) with diagnosed IBD (Crohn's disease, ulcerative colitis, unclassified IBD) with or without comorbidity, with or without therapy at the time of inclusion, age = 20 years and living in Germany.

Exclusion criteria

Exclusion criteria: When inclusion criteria cannot be met.

Design outcomes

Primary

MeasureTime frame
The online survey has been taken place in 2020 from August 25 to December 10. The following questions should be answered by conducting this survey-based study: 1) How did the pandemic and the lock-down impact medical care? a) on planned but postponed or cancelled outpatient or inpatient visits or surgery appointments, b) to the IBD associated medication (reduction, reorientation) by the physicians (general practitioners, at IBD outpatient clinic) or patients/parents (without consulting a physician) so far? c) How many patients have postponed a planned outpatient visit for infusion of biologicals due to symptoms / COVID-19 contact / return home from high-risk areas / occupational exposure as indicated in the telephone/ e-mail consultation? d) Did any IBD flare occur during a pandemic-related change in care/ medication?

Secondary

MeasureTime frame
2) How have patients experienced "tele-medicine" practiced in the clinic setting so far? Did they consider that they received sufficient information and care? 3) How did the pandemic influence social factors and mental health of the IBD patients regarding medication and severity of the disease? Are there any variations compared to the KoCo-19 cohort?

Countries

Germany

Contacts

Public ContactThu Giang Le Thi

LMU Klinikum, Dr. von Haunersches Kinderspital, Abt. Pädiatrische Gastroenterologie & Hepatologie

kococedkk@med.uni-muenchen.de+4989440057854

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026